Clinical Trial Update: Multi-parametric Biomarker Development to Predict Malignant Conversion in Patients With Neurofibromatosis Type 1

View source ↗

Summary

This Johns Hopkins University study is developing multi-parameter biomarkers to predict malignant transformation in Neurofibromatosis type 1, focusing on malign…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Neurofibroma
• Malignant Peripheral Nerve Sheath Tumor
• Neurofibromatosis Type

Snippet

Sponsor: Johns Hopkins University | Conditions: Neurofibromatosis 1, Malignant Peripheral Nerve Sheath Tumor (MPNST) of Soft Tissue (Diagnosis) | Status: ACTIVE_NOT_RECRUITING